Mohawk Industries, Inc. (NYSE: MHK) — Global Scale, Sub-Par Returns: A Range-Bound Cyclical Priced for the Turn

Report date: 2026-08-08 · Price at 2026-08-07 close: $136.06 · Market capitalisation: ~$8.23bn · Enterprise value: ~$9.30bn Sector: Producer Manufacturing · Building Products (Flooring) · CIK: 0000851968 · Coverage: Initiation

⚡ Claude’s Take

This block is the author’s own independent opinion. It is general information, not investment advice. The analysis in Sections 1–15 below takes no position, carries no price target, and makes no buy or sell recommendation.

Verdict: AVOID at $136 — but this is not a short. Revisit below ~$100, with real interest at ~$85–95 (roughly 0.60–0.70× book).

Mohawk is the largest flooring manufacturer on earth and one of the least rewarding businesses I have looked at this year. The number that settles it: over the last ten years an owner of this stock compounded at negative 4.2% per annum while absorbing a 79% drawdown, and over the last five years at negative 6.9%. Every factor-similar peer did better — Armstrong World +16.8%, Masco +9.5%, Interface +8.8%, Fortune Brands +0.8%. That is not bad luck across one cycle; it is the market correctly pricing a business that earned 3.7% return on invested capital in FY2025 against a cost of capital near 9.5%, whose gross margin has fallen 750 basis points since 2016, and which wrote off $1.57bn of goodwill and intangibles in 2022–23 — the verdict on a decade of acquisitions. The company’s own proxy discloses the scoreboard: $100 invested returned $77.55 while the peer group returned $168.32. Scale here is real, but it is scale without customer captivity — no switching costs, no network effects, a once-a-decade purchase, and a 10-K that admits to import pressure and regions with surplus capacity. That is a cost position, not a moat, and it is being competed away.

The reason this is not a short, and the reason I would happily own it lower, is that the cyclical set-up is genuinely attractive and the balance sheet is genuinely strong. Housing turnover sits at 30-year lows, net debt is 0.8× EBITDA, the company generated $811m of trailing free cash flow, and at 0.96× book MHK is the cheapest way in its peer group to own a flooring recovery — most comps trade in the 74th–92nd percentile of their own valuation histories while MHK’s price-to-book sits at the 40th. What I object to is the entry point, not the asset. After a +44% move off the May low the stock sits 2.6% from its 52-week high, at the top of the $76–$164 band it has traded inside since 2022, and the embedded expectations now require roughly a 10% operating margin — near peak-cycle, achieved in only two of the last ten years — merely to earn the cost of capital. The framing matters and the factor model settles it: despite being up 32% in a quarter, MHK’s Momentum loading is approximately zero (+0.03). This is not a momentum re-rating and it is not a falling knife; it is a high-beta, deep-value, housing-levered cyclical (Market +1.44, Home Construction +1.16, InterestRate −0.25) that has been carried up by a rate-and-housing rally, into the top of its range, on earnings flattered by $0.63 per share of non-recurring tariff refunds — 17% of the quarter’s adjusted EPS, which management’s own third-quarter guide already gives back. Two further things keep me out at this price: not one insider bought a single share on the open market across 99 Form 4 filings in nineteen months, including at the $94 low; and the 2026 proxy discloses a clawback of 2023–24 incentive compensation following a restatement of accounts-receivable and intercompany activity.

Conviction: medium. What flips me bullish: two or more consecutive quarters of consolidated margin expansion that survives stripping out tariff refunds — specifically Flooring North America sustaining an 8%+ segment margin — together with evidence of actual capacity closure in ceramic or LVT, which would mean the restructuring savings are being kept rather than competed away. What flips me bearish: housing turnover genuinely recovers and MHK’s incremental operating margins still come in below 20%, proving the cycle turn accrues to distribution and imports rather than to the manufacturer — at which point the asset-value floor is the only argument left, and book value in a business earning 4% on capital is not worth book.

Tag: The world’s largest flooring maker is not the world’s best flooring business.

📈 Stock Price Action — Five-Year Event Map

Mohawk has completed a five-year round trip to nowhere with extraordinary violence along the way. The shares peaked at $209.80 on 12 August 2021, collapsed 47% through 2022, bottomed at $76.56 on 27 October 2023, more than doubled into July 2024, and have since oscillated between roughly $92 and $164 without net progress. The last close was $136.06 (7 August 2026), against a 52-week range of $94.33–$139.75 — placing the stock 2.6% below its 52-week high, +44.2% above its May 2026 low, and still 52.2% below its all-time closing high of $284.82 (1 December 2017). The company has never paid a dividend and has not split since 1997, so the adjusted and unadjusted price series coincide over this window.

Cycle narrative. (1) The 2021 peak was a COVID-remodelling artefact; the subsequent 54% collapse tracked the fastest tightening cycle in forty years, a European gas shock that hit Mohawk’s energy-intensive ceramic and panels plants directly, and the unwinding of pandemic-era demand pull-forward. (2) The autumn-2022 bounce was macro, not company news — the +14.70% session on 10 November 2022 was a CPI print, which tells you what actually drives this equity. (3) By October 2023 the stock made its cycle low at $76.56 as thirty-year mortgage rates peaked and existing-home turnover fell toward multi-decade lows. (4) The 110% recovery into July 2024 combined a Fed-pivot repricing with a genuine earnings beat — the +19.49% single-session move on 26 July 2024 remains the largest of the five years. (5) That optimism reversed hard: a −13.82% session on 25 October 2024 followed disappointing guidance, and April 2025’s tariff announcements took the shares to $98.63. (6) The tariff pause produced a +10.46% day on 9 April 2025 and a 42% rally into a 52-week high that September. (7) The subsequent 33% drawdown to $94.33 on 19 May 2026 reflected deteriorating FY2025 results — operating margin fell from 6.40% to 4.54% — compounded by conflict-driven European energy inflation. (8) The current 44% surge has three identifiable legs: the 11 June 2026 CEO succession announcement (+7.47%, an 8-K naming Paul De Cock to succeed Jeffrey Lorberbaum effective 30 September), a +9.60% session on 24 June 2026 for which no company filing exists and which is therefore attributed to sector and macro factors, and the Q2 2026 earnings response on 3 August (+8.03%). The price moves are Fact; every attributed cause is Interpretation.

1. Executive Summary

Mohawk Industries is the world’s largest flooring manufacturer by annual sales, operating 19 countries of manufacturing with sales into roughly 180, across three segments: Global Ceramic ($4.29bn FY2025 revenue), Flooring North America ($3.64bn) and Flooring Rest of the World ($2.86bn). It makes ceramic and porcelain tile, natural stone, quartz countertops, broadloom carpet and carpet tile, laminate, wood, LVT and sheet vinyl, plus a European panels, insulation and roofing-elements business. It has never paid a dividend.

The business does not earn its cost of capital, and has not for most of a decade. FY2025 return on invested capital was 3.69% on the ROIC.ai calculation and 3.87% on our own recomputation from the filings; the trailing-twelve-month figure through 4 July 2026 is 4.69%, or 5.91% excluding goodwill and intangibles. Against an estimated WACC of roughly 9.5%, Mohawk destroyed value in each of the last two fiscal years. Gross margin has fallen from 31.4% in 2016 to 23.9% in FY2025; consolidated operating margin from 14.3% to 4.5%. Revenue in FY2025 of $10,785m was 8.1% below FY2022 and only 13.6% above FY2016 — nine years without organic progress despite continuous acquisition and roughly $5.5bn of cumulative capital expenditure.

There is no durable competitive advantage. Mohawk has genuine scale, but scale without customer captivity. Flooring is a once-a-decade, specified-per-project purchase with no switching costs, no network effects, and brands that command shelf position rather than price. The 10-K itself concedes pressure “from imported ceramic products as well as alternate flooring categories” and notes regions with capacity sufficient to serve domestic demand and export the surplus. In Greenwald’s taxonomy this is a cost position in a fragmented industry, not a barrier to entry — and both diagnostic tests (market-share stability, sustained high ROIC) fail.

Capital allocation has been the primary destroyer of value. The company repurchased $900.3m of stock in FY2021 at an average price near $180 — the largest buyback in its history executed at the cycle peak — and repurchased nothing in 2023, the year the stock bottomed at $76.02. The 2022–23 impairments of $695.8m and $877.7m wrote off a decade of acquisition premia across all three segments. The 2026 proxy’s own pay-versus-performance table shows a five-year TSR of $77.55 per $100 invested against a peer group’s $168.32.

The counter-argument is real and deserves weight. Net debt of $1.06bn is 0.8× EBITDA; the company generated $811m of trailing free cash flow and $236m in the first half of 2026; a new $1.5bn unsecured revolver was signed in May 2026. Housing turnover in Mohawk’s major regions sits near 30-year lows — a cyclical trough, not a permanent state — and US and European rates have fallen to their lowest since autumn 2022. Q2 2026 was a genuine beat: sales +6.8%, GAAP operating income +34% to $253.7m, with Flooring North America’s segment margin nearly doubling to 10.0%. At 0.96× book and the 40th percentile of its own price-to-book history, Mohawk is the cheapest liquid way to own a flooring recovery among listed peers, most of which trade in the 74th–92nd percentile of their own valuation ranges.

The valuation question is therefore about entry, not about the asset. At an enterprise value of $9.30bn, the market requires roughly $883m of NOPAT — implying an EBIT of ~$1,118m and a 10.0% operating margin — merely to earn a 9.5% cost of capital. Mohawk’s trailing operating margin is 5.10%, and it has achieved 10%+ in only two of the last ten years, both demand booms. At the ten-year median margin of roughly 8%, the return on today’s enterprise value is 7.6% — still below cost of capital. The stock is not pricing a normalisation; it is pricing a return to peak.

Two governance facts belong in the summary. Across 99 Form 4 filings since January 2025 there is not one open-market purchase by any insider, including through the May 2026 low of $94.33; the August 2026 transactions were all sales, all executed under pre-existing Rule 10b5-1 plans. And the 2026 proxy discloses that following the FY2025 revision of the 2023 and 2024 financial statements — an accounts-receivable and intercompany error that reduced receivables by $42.1m and cut 2023 and 2024 EPS by $0.15 and $0.05 — the company was required to claw back erroneously awarded incentive compensation.

Jeffrey Lorberbaum retires as CEO on 30 September 2026 after 25 years, remaining Chairman; Paul De Cock, a 2005 Unilin acquiree who has run Flooring North America and latterly served as COO, succeeds him. The Lorberbaum family retains 16.5% of the shares.

No recommendation and no price target appears in this section or anywhere in Sections 1–15.

2. Business Overview

2.1 What the company does

Mohawk Industries designs, manufactures, sources, distributes and markets flooring for residential and commercial end markets. Incorporated in Delaware in 1988 and headquartered in Calhoun, Georgia, it traces its lineage to the carpet industry of north-west Georgia and reached its present scale through a three-decade acquisition programme: Aladdin Mills (1994), Dal-Tile (2002), Unilin (2005), Marazzi (2013), IVC (2015), Godfrey Hirst (2018), and a long tail of smaller regional deals. As of 31 December 2025 it employed approximately 40,500 people — 15,600 in the United States, 13,600 in Europe and 11,300 elsewhere — with manufacturing in 19 countries and sales into approximately 180.

The business is genuinely global and genuinely industrial. It owns kilns, extruders, tufting machines, presses and lamination lines; property, plant and equipment stood at $11,036m at cost and $4,604m net at 4 July 2026 against $13,823m of total assets. This is a heavy-fixed-cost manufacturer, and that fact governs almost everything about its economics: operating leverage is violent in both directions, and utilisation — not price — is the dominant margin variable in any given quarter.

2.2 Revenue segmentation

Mohawk reports three segments. FY2025 results, with segment operating income taken from the 10-K segment note:

Two observations. First, Flooring North America — a third of revenue — earned a 3.12% operating margin in FY2025, down from 6.30%. This is the legacy carpet business plus North American laminate, wood and LVT, and it is the weakest asset in the portfolio. Second, general corporate expense nearly doubled from $58.5m to $103.4m without a segment-level explanation in the 10-K; part is likely the SAB 108 cumulative correction discussed in the relevant section, but the filing does not bridge it. That is an open question for management.

By product category, FY2025 revenue was Ceramic & Stone $4,220.1m (39.1%), Carpet & Resilient $3,734.8m (34.6%), Laminate & Wood $1,752.3m (16.2%) and Other $1,078.2m (10.0%) — the last comprising roofing elements, insulation boards, chipboards and intellectual-property licensing, almost entirely a European business housed inside Flooring ROW.

Geographically, in Q2 2026 the United States contributed $1,592.0m (53.2%) of the $2,991.4m quarter, Europe $985.2m (32.9%), Latin America $200.6m (6.7%) and Other $213.6m (7.1%). Russia revenue remains consolidated within Europe — a residual disclosure risk discussed in the relevant section.

2.3 How it makes money, and to whom it sells

Mohawk sells through an unusually wide channel set: company-owned service centres and stores, company-operated distributors, independent floor-covering retailers, wholesalers, mass merchandisers, home centres, buying groups, ceramic-tile specialists, e-commerce retailers, residential builders, commercial contractors and commercial end users. In several markets it controls its own distribution — a point management leaned on in the Q2 2026 call when arguing that channel pre-buying ahead of price increases was limited because “we really hold the inventory for the customer.”

This vertical integration into distribution is a real operational asset. It gives Mohawk service advantages, shelf control and better demand signal than a pure manufacturer selling into third-party distribution. It is also, however, an additional layer of fixed cost and working capital: the cash conversion cycle ran at roughly 130 days through 2025–26, and inventories of $2,586m at 4 July 2026 represent about 22% of trailing revenue.

Revenue is essentially entirely non-recurring. There is no subscription, no razor-and-blade, no installed-base annuity. The only recurring-revenue analogue is the intellectual-property licensing line inside “Other,” where Mohawk licenses Unilin’s laminate-locking and related patents to third-party manufacturers — high-margin but small, and disclosed only inside an aggregated category. Everything else is a one-time sale of a product a consumer replaces roughly once a decade and a commercial customer replaces on a seven-to-twelve-year refit cycle. Demand is therefore a direct function of housing turnover, new construction starts and commercial refurbishment activity — none of which Mohawk influences.

2.4 Cost structure

Cost of sales was 76.1% of revenue in FY2025 against 68.6% in FY2016. The input set is energy (natural gas for kilns and dryers, particularly acute in Europe), petrochemical derivatives (nylon and PET for carpet fibre, PVC for LVT and sheet vinyl), clay bodies and glazes, wood fibre, and freight. Management disclosed $77m of underlying inflation in Q2 2026 alone, with a further $35m sequential step-up expected into Q3 and Q4 “elevated.” European natural gas is explicitly called out as the pressure point, and Mohawk hedges only “a portion of our near-term requirements.”

This is the structural vulnerability. A manufacturer with pricing power passes input inflation through with a lag and keeps the spread. Mohawk’s own language on the Q2 call was that “the whole industry really needs to take pricing to cover” rising costs — pricing to cover costs, not to expand margin. That is the language of a price-taker in a competitive market, and the 750bp decline in gross margin since 2016 is what it looks like in the accounts.

2.5 Verdict

A genuinely large, genuinely global, genuinely industrial business with no recurring revenue, no pricing power and a cost structure exposed to energy and petrochemicals that it can hedge only partially. The scale is real and the distribution integration is a genuine operational asset. But the revenue model is one-time sales of a deferrable durable into a demand pool set entirely by housing turnover, and the cost model passes input inflation through only with lag and only to the extent competitors do the same. Understandable, yes. High-quality, no.

3. Industry Dynamics

3.1 Structure and size

The global flooring market is large, mature and highly fragmented. The US flooring market alone was valued at roughly $117bn in 2025, projected at ~$124bn in 2026. Mohawk’s ~$10.8bn of global revenue makes it the largest single manufacturer, yet even in ceramic — where it is the world’s largest producer — the 10-K describes the industry as “significantly fragmented.” No participant approaches the share concentration that would permit price leadership.

The value chain runs: raw materials (clay, energy, petrochemicals, fibre) → manufacturing (Mohawk, Shaw/Berkshire Hathaway, Tarkett, Interface, Armstrong Flooring successors, and a very long tail of Chinese, Indian, Turkish, Spanish, Italian and Brazilian ceramic producers) → distribution (independent distributors, some manufacturer-owned) → retail (Floor & Decor, Home Depot, Lowe’s, independent flooring retailers, buying groups) → installation (fragmented local contractors) → end customer.

The profit pool has migrated downstream. This is the single most important structural fact in the industry and it is visible in the market’s own pricing: Floor & Decor, a specialty retailer with no manufacturing, trades at 2.77× book and 34× earnings; Mohawk, which owns the kilns, trades at 0.96× book. Retail captures the customer relationship, carries less fixed cost, turns inventory faster and is not exposed to energy. Manufacturing carries the capital intensity and absorbs the volatility.

3.2 Competitive intensity

Competition in flooring is intense on three axes simultaneously.

Intra-category. Within ceramic, Mohawk competes against domestic producers and against imports from Spain, Italy, Turkey, India, Brazil and China. The 10-K’s own framing is decisive: “certain regions around the world have established sufficient capacity to allow them to meet domestic needs” and export the surplus. A manufacturer facing an import stream priced off someone else’s marginal cost cannot set price.

Inter-category. Ceramic competes against LVT; LVT competes against laminate; laminate competes against engineered wood; all hard surfaces compete against carpet. Mohawk participates in every category, which is often presented as a strength — and in one respect it is, because category share shifts are revenue-neutral to Mohawk. But it is also the reason no single category position is defensible: Mohawk cannot defend ceramic pricing by pointing to a lack of substitutes, because it manufactures the substitutes.

Against the channel. Large retail customers — home centres, Floor & Decor, buying groups — possess meaningful buyer power and can and do source private-label product directly from Asian manufacturers.

3.3 The capital cycle — where the industry sits

Applying Marathon’s supply-side lens, flooring is in the late-oversupply phase of a capital cycle that has not yet cleared. Capacity was added aggressively through the 2010s in global ceramic and, from roughly 2018, in LVT — a category whose US share rose from about 17% in 2022 to 26% in 2023 and which attracted very large Asian capacity additions. Demand then spiked in 2020–21 on pandemic remodelling, validating the build-out, and collapsed from 2022 as rates rose. The capacity remains.

Two supply-side signals matter for the forward view. First, the 10-K’s admission of surplus regional capacity is the classic tell that returns will stay suppressed until closures occur. Second, LVT has matured — management conceded on the Q2 2026 call that “LVT demand has trended more in line with the overall flooring industry given that LVT is becoming a more mature category.” A maturing category with excess capacity and low switching costs is a price war waiting for a catalyst.

The absence of visible capacity closure is the key negative. Marathon’s framework says returns recover when capital exits, not when demand returns. Mohawk’s restructuring programmes — including the newly announced ~$60m savings for ~$50m of cash cost by end-2027 — are its own capacity and cost rationalisation, which helps Mohawk specifically. Industry-wide closure is what would lift the whole price level, and there is no evidence of it in the filings or the trade press reviewed.

3.4 Demand drivers and the regulatory overlay

Demand is set by three variables, none within Mohawk’s control:

• Housing turnover. The dominant driver, because most flooring is replaced within 12 months either side of a sale. US existing home sales fell to roughly a 30-year low, and the FY2025 10-K states turnover “remained near historically low levels, driven by affordability challenges.” Management’s Q2 2026 framing was blunter: “the home resale market remains near multi-decade lows.”
• New residential construction. “Remains soft” per management, pressured by affordability.
• Commercial refurbishment. The relative bright spot: commercial “remained stable through 2025” and “continued to outperform residential” in Q2 2026. Mohawk has meaningful commercial exposure in both Global Ceramic and Flooring NA.

The regulatory overlay is trade policy, and it currently runs in Mohawk’s favour. Tariffs on imported flooring inputs generated refunds worth approximately $0.63 per share in Q2 2026 and a further ~$0.12 guided into Q3 — reversals of costs Mohawk had previously absorbed. Separately, the International Trade Commission has proposed minimum tariffs of 25% on countertops to protect domestic producers, with a Presidential decision pending as of 31 July 2026; Mohawk has pre-positioned by commissioning a second US countertop manufacturing line. This is a genuine, quantifiable benefit — and it is entirely policy-dependent and reversible, which is precisely why it should not be capitalised into a valuation.

3.5 Verdict

Structurally a bad industry. It is fragmented, capital-intensive with punishing fixed-cost leverage, exposed to globally traded commodity inputs and to low-cost import competition, dependent on a demand variable no participant can influence, and currently oversupplied following a capacity build that has not been rationalised. The profit pool sits with specialty retail, not manufacturing — a judgement the equity market has already rendered in the relative multiples. The one genuine positive is cyclical rather than structural: with turnover at 30-year lows, deferred replacement is accumulating, and flooring is deferrable but not avoidable. The industry question is not whether volume recovers, but whether the recovery accrues to manufacturers or is competed away by idle capacity. On the evidence, the burden of proof sits with the bulls.

4. Competitive Position

4.1 Naming the moat — or its absence

The disciplined way to answer this is to run Greenwald’s taxonomy explicitly. There are exactly three genuine competitive advantages: supply-side (cost), demand-side (customer captivity), and economies of scale combined with captivity. Everything else — brand, technology, quality, service — is a differentiator that competition erodes.

Demand-side captivity: absent. Captivity requires habit, switching costs or search costs. Flooring fails all three. A consumer buys flooring roughly once a decade, which is far too infrequent to build habit. Switching costs are zero — the product is selected from samples at point of sale, and a retailer can substitute a competing SKU without penalty. Search costs are low and falling, with specialty retail and e-commerce making comparison trivial. There is no evidence in the financials of captivity: if customers were captive, price increases would stick and gross margin would be stable. It has fallen 750bp in nine years.

Network effects: absent. There is no mechanism by which one additional Mohawk customer makes the product more valuable to the next. This should not require argument, but it is worth stating plainly because “scale” is frequently conflated with “network.”

Supply-side cost advantage: partial, and eroding. This is the only category where Mohawk has a genuine claim. It is the largest producer, it is vertically integrated into distribution, it operates the Italian R&D centre from which product development is leveraged globally, and it holds a real patent estate in laminate locking systems (the Unilin intellectual property, which it licenses to third parties). Scale should deliver purchasing leverage, plant-level utilisation and distribution density.

But a cost advantage only counts if it produces sustained excess returns, and Mohawk’s does not. ROIC has run: 11.78% (2016), 11.05% (2017), 8.80% (2018), 7.57% (2019), 4.96% (2020), 9.40% (2021), 0.31% (2022), negative (2023), 5.31% (2024), 3.69% (2025). The ten-year average is roughly 6% against a cost of capital near 9.5%. A cost advantage that cannot deliver returns above the cost of capital across a full cycle is not an advantage — it is table stakes in a business where the marginal producer, frequently an importer with a lower energy and labour cost base, sets the price.

Brand: real, but not pricing power. Daltile, Marazzi, American Olean, Karastan, Pergo, Quick-Step, Godfrey Hirst, Moduleo and Unilin are recognised names that earn shelf space and specification. The test of a brand moat, however, is whether removing the brand would deteriorate a financial outcome — and here the outcome to inspect is gross margin, which has fallen steadily while the brands remained. The brands help Mohawk sell volume; they do not let it hold price.

4.2 The two diagnostic tests

Greenwald offers two objective tests, and Mohawk fails both.

Market-share stability. Genuine barriers produce stable shares over long periods. Mohawk’s revenue was $8,959m in 2016 and $10,785m in 2025 — but the industry grew too, and the FY2025 figure is 8.1% below FY2022. More tellingly, the composition changed through acquisition rather than organic gain. Management asserts share gains “in most regions” and specifically in both hard and soft surfaces in Flooring NA, but supplied no third-party data on the call. Treated as hypothesis (the relevant section rule 8), not evidence.

Sustained ROIC. Covered above: it fails decisively.

There is a further point worth making about the share-gain claim even if it is true. Share gained while a segment earns a 3.1% operating margin is share bought with capital, not share earned through advantage. The relevant question is not whether Mohawk adds a point of share but whether the incremental point clears the cost of capital. Flooring North America’s FY2025 margin says it does not.

4.3 Direct competitive comparison

Two readings, and both matter. Mohawk is the worst ten-year performer in its own factor-similar peer set and the only negative one. Armstrong World is the instructive contrast: a business with a genuine oligopoly in mineral-fibre ceilings — high share, real switching costs at the specification stage, and consequently high and stable ROIC — compounded at +16.8% while Mohawk compounded at −4.2%. Both sell building products into the same construction cycle. The difference is industry structure and barriers to entry, not management effort. Interface, similarly, occupies a defensible niche in modular commercial carpet tile with design-led specification.

The second reading cuts the other way and must be given its weight: Mohawk is not the expensive name in this group. Most peers sit at the 74th–92nd percentile of their own valuation histories; Mohawk’s price-to-book sits at the 40th. If a flooring recovery arrives, Mohawk offers more operating and valuation leverage to it than anything else listed. That is a legitimate argument — it is an argument about price, not about quality.

4.4 Verdict

Crowded market, weak differentiation, no durable advantage. Mohawk has genuine scale and a genuine cost position, but in an industry where fragmented global capacity and low-cost imports set the marginal price, that scale has not produced returns above the cost of capital in any year since 2018 — and only marginally then. Applying that discipline: a moat claim that cannot be tied to a financial outcome that would deteriorate without it is not a moat. Remove Mohawk’s brands and its scale, and the gross margin would be lower — but it would be lower than 23.9%, not lower than some defended 31%. The 750 basis points already surrendered since 2016 is the erosion, in real time, of an advantage that was never a barrier to entry.

5. Growth History and Forward Opportunities

5.1 The historical record

The pattern is unambiguous. Revenue peaked in FY2022 and is 8.1% below that level. More damning: revenue grew 33.6% from 2015 to 2025 — 2.9% compound — while operating margin halved and ROIC fell by more than half. Growth was purchased, not compounded. Cumulative acquisition spend over 2018–2025 alone was roughly $1.5bn ($569.0m in 2018, $81.1m in 2019, $124.0m in 2021, $209.6m in 2022, $515.4m in 2023, $6.9m in 2025), and cumulative capital expenditure over the same period roughly $4.1bn. Against that, revenue is lower than it was in 2022 and operating income is 55% below 2021.

Organic versus acquired. Mohawk does not disclose a clean organic bridge, which is itself a disclosure weakness. What can be established from the filings is that the 2015–2018 growth phase coincided with the IVC and Godfrey Hirst acquisitions and heavy greenfield LVT and ceramic capacity investment; that 2021’s +17.3% was a pandemic-demand and price artefact; and that every year since has declined. On a constant-currency basis Q2 2026 revenue grew 5.0% against 6.8% reported — so roughly 180bp of the recent growth is euro translation, not volume or price.

5.2 The current quarter, honestly assessed

Q2 2026 was a real beat and should be credited as one. Net sales of $2,991.4m rose 6.8% (5.0% constant currency); GAAP operating income rose 34.4% to $253.7m (8.48% margin against 6.73%); gross margin expanded 109bp to 26.58%; SG&A fell 66bp as a percentage of sales. Every segment grew. Flooring North America’s segment operating margin nearly doubled, from 5.55% to 10.02%.

But three qualifications are material.

First, the tariff refunds. Adjusted EPS of $3.67 included approximately $0.63 from tariff refunds that were not in guidance — about 17% of the adjusted figure, and roughly $48m pre-tax, or 1.6 points of operating margin. Management confirmed these are reversals of previously absorbed costs, and the Q3 guide includes only ~$0.12 more. Ex-refund, Q2 adjusted EPS was approximately $3.04.

Second, the quarter borrowed from the next. Management attributed the upside to “initial stocking of new product placements and limited increases in inventory by some customers ahead of announced price increases,” and guided that the normal Q2-to-Q3 sequential decline “could be more pronounced than in past years.” Pressed by Evercore on the historical average sequential decline of about 4.5%, management confirmed the drop would likely exceed it.

Third, the guide implies deterioration. Q3 adjusted EPS guidance of $2.50–$2.60 including ~$0.12 of refunds gives a baseline of $2.38–$2.48 — a 19–22% sequential decline from the $3.04 ex-refund Q2 base — driven by a further ~$35m sequential step-up in underlying inflation, with Q4 “elevated” and carrying four fewer shipping days.

5.3 Forward opportunities

The genuine forward drivers, in descending order of credibility:

Housing-turnover normalisation (high credibility, unknown timing). This is the entire bull case and it is a sound one. Existing home sales at a 30-year low is a cyclical trough. US mortgage rates and European rates have fallen to their lowest since autumn 2022, and the 10-K notes elevated consumer savings, lower inflation and stable employment as conditions that “may support greater participation in the housing market.” Deferred flooring replacement accumulates. When turnover normalises, Mohawk’s operating leverage works violently in its favour — incremental margins on existing capacity should be high.

Restructuring and productivity (medium credibility). The new programme targets ~$60m of annual savings for ~$50m of cash cost, most complete by end-2027, on top of prior programmes contributing $43m of benefit in Q2 2026 alone. The savings are real at the line-item level. The scepticism is at the consolidated level: Mohawk has been in continuous restructuring for years, and consolidated operating margin still fell from 6.40% to 4.54% in FY2025. Either the savings are not permanent, or they are being competed away in price. Management’s claim that these are “permanent structural improvements to our cost base, not temporary measures” is a claim the multi-year margin path does not support.

Premium mix and new product placement (medium credibility). Genuine and visible in the quarter — premium tile and countertop placements in the US, premium LVT and laminate collections in Europe, an anti-allergen carpet product, and the Hero rubber flooring line made with recycled Nike regrind that won three Best of NeoCon awards. Commercial continues to outperform residential and carries better mix. This is competent product management and it does support share and mix.

Countertop trade protection (medium credibility, binary). The proposed 25% ITC minimum tariff, with a second US line already commissioned, is a clean quantifiable opportunity — if the Presidential decision goes Mohawk’s way. Policy-dependent and therefore not capitalisable.

What is not a forward driver: LVT category growth, which management conceded has converged to industry growth as the category matures. The mix-shift growth thesis that justified heavy 2018–2022 LVT investment has expired.

5.4 Verdict

Low-quality growth historically; genuinely leveraged cyclical recovery prospectively. The ten-year record is of revenue purchased with acquisition and capex while margins and returns halved — the textbook definition of growth that destroys value. Prospectively, the operating leverage into a housing-turnover recovery is real and is the single best argument for owning the equity. But the quality question is not whether revenue recovers; it is whether the recovery converts to returns above the cost of capital. With industry capacity un-rationalised and Mohawk’s own pricing language being “cover costs” rather than “expand margin,” the base case must be that a good portion of any volume recovery is competed away.

6. Financial Quality

6.1 Revenue and margin structure

The margin decline is the central financial fact and it deserves to be shown in full:

Gross margin has fallen 753 basis points from the 2017 peak to FY2025, and SG&A has risen 185bp as a share of sales over the same span. The 2021 recovery to 29.18% was a pandemic-pricing artefact that reversed entirely within two years. Q2 2026’s 26.58% is a genuine improvement — but it is inflated by the tariff refunds and remains 500bp below 2017.

This is the diagnostic. A business with pricing power holds gross margin through an input-cost cycle. Mohawk’s gross margin fell during the 2021–23 inflation and has only partially recovered during the subsequent disinflation. That is the signature of a price-taker.

6.2 Returns on capital — the decisive metric

FY2025, computed from the filings rather than accepted from the feed:

• EBIT $489.8m × (1 − 21.08% effective tax) = NOPAT $386.5m
• Invested capital = equity $8,378.7m + total debt $2,457.3m − cash $856.1m = $9,979.9m
• ROIC = 3.87% (ROIC.ai independently computes 3.69%)

LTM through 4 July 2026:

• EBIT $570.5m × 0.79 = NOPAT $450.7m
• Invested capital = equity $8,544.7m + debt $1,911.5m − cash $849.6m = $9,606.6m
• ROIC = 4.69%; excluding $1,983.5m of goodwill, tradenames and other intangibles, 5.91%

Against an estimated WACC of roughly 9.5% (beta 1.256, ~19% debt-to-capital, 5% equity risk premium, ~4% after-tax cost of debt), Mohawk earned approximately half its cost of capital in FY2025 and is running at roughly half at the current trailing rate. Return on equity was 4.66% in FY2025, down from 17.50% in 2016.

Even the ex-goodwill figure of 5.91% — the fairest read of the operating business, stripped of acquisition premia — remains 350bp below the cost of capital. The gap between the two measures is itself the capital-allocation critique in one number: roughly two percentage points of return are consumed by paying for acquisitions that did not earn their price.

6.3 Cash generation

Here the picture is materially better, and the bull case lives here.

Free cash flow is consistently positive and consistently exceeds net income, which reflects a depreciation charge ($652.6m in FY2025) that substantially exceeds current capital spending. Cash conversion is genuinely good and is the strongest thing about the financial profile.

But two cautions. First, capex has run below depreciation for two consecutive years — $454.4m against $638.3m in 2024, and $440.0m against $652.6m in 2025, or 67% of depreciation. That is a harvest posture. It flatters free cash flow and is defensible during a downturn, but it is not consistent with management’s stated “invest in the business first” capital-allocation priority, and it cannot persist indefinitely without eroding the asset base. FY2026 planned capex of ~$460m keeps the pattern. Second, the LTM figure of $811.5m is flattered by working capital: H1 2026 operating cash flow of $426.6m more than doubled H1 2025’s $210.0m, with $171.0m coming from accounts payable and accrued expenses. The cleaner run-rate is the FY2025 figure of ~$616m.

6.4 Balance sheet

Genuinely strong, and this is not in dispute.

At 4 July 2026: cash $849.6m; total debt $1,911.5m (of which $761.4m current); net debt $1,061.9m; total equity $8,544.7m; total assets $13,823.2m. Net debt to EBITDA of 0.8× on management’s calculation. A new $1.5bn unsecured revolving credit facility was signed on 12 May 2026 with JPMorgan Chase and J.P. Morgan SE as agents, replacing the 2019 facility, with a $125m letter-of-credit sublimit, $150m swingline and an accordion feature.

Net debt has fallen steadily — $1,683.6m at Q1 2025, $1,654.3m at Q2 2025, $1,402.7m at Q3 2025, $1,174.4m at Q4 2025, $1,239.0m at Q1 2026, $1,061.9m now. Book value per share is $141.17 against a share price of $136.06, so the equity trades slightly below book. Tangible book, deducting $1,983.5m of goodwill and intangibles, is approximately $108.4m per share — the shares trade at ~1.26× tangible book.

The balance sheet gives Mohawk something most cyclicals in a trough do not have: the capacity to survive a prolonged downturn without dilution, and the optionality to buy assets or its own stock at distressed prices. Whether it uses that optionality well is the relevant section’s question.

6.5 Dilution and share-based compensation

Modest and well-controlled. Stock-based compensation was $30.0m in FY2025 — 0.28% of revenue and 8.1% of net income — against $27.5m in 2024 and $20.9m in 2023. Weighted-average diluted shares fell from 74.8m (2017) to 62.4m (2025), with 60.5m outstanding at 4 July 2026. There is no dilution problem here; SBC is a rounding error relative to the enterprise. This is a conventional industrial compensation structure, not a technology-style equity giveaway.

6.6 Accounting quality — a genuine flag

During Q4 2025 Mohawk identified an error in intercompany activity affecting accounts receivable. Under SAB 108 it concluded the cumulative correction would be material to FY2025 and therefore revised the previously issued 2023 and 2024 financial statements. The specifics: accounts receivable reduced by $42.1m across affected prior periods; 2023 net earnings reduced by $9.5m ($4.1m to cost of sales, $5.4m to other expense; EPS −$0.15); 2024 net earnings reduced by $3.0m ($1.2m and $1.8m respectively; EPS −$0.05); retained earnings at 31 December 2022 reduced by $29.6m.

Management concluded disclosure controls remained effective. The amounts are individually small against a $10.8bn revenue base — roughly 0.4% of receivables. But three things make this more than a footnote. It went undetected for at least three years. It concerned intercompany activity, which is where a 19-country manufacturer’s control environment is most tested. And it was consequential enough to trigger the Dodd-Frank clawback described in the relevant section. Combined with the unexplained near-doubling of general corporate expense to $103.4m in FY2025, the accounting deserves closer-than-average monitoring rather than dismissal.

6.7 Verdict

Economics do not improve with scale — they have deteriorated with it. Mohawk today is 20% larger by revenue than in 2016 and earns less than a third of the operating margin and a third of the return on capital. The balance sheet is strong, dilution is negligible, and cash conversion is good. But cash generation in a business earning 4–5% on capital is a liquidation-quality virtue, not a compounding one: it means the assets throw off cash faster than they earn a return, which is exactly what a mature business in an oversupplied industry should do. The accounting flag is small in dollars and non-trivial in what it implies about a sprawling international control environment.

7. Capital Allocation

This is where the thesis is decided, and the record is poor.

7.1 The buyback record

Mohawk has never paid a dividend in its history as a public company since the 1992 IPO. All shareholder return has come through repurchase:

The pattern is textbook pro-cyclical. The largest repurchase in company history — $900.3m, more than the previous three years combined — was executed in FY2021 at an average price near $180, in a year the stock ranged $134 to $232. The stock is $136.06 today. That single year’s capital deployment has lost roughly a quarter of its value, permanently, and it represented approximately 11% of the current market capitalisation. Then, in 2023, with the stock at its cycle low of $76.02 and the balance sheet still investment-grade, Mohawk repurchased nothing at all.

Buying maximum stock at maximum price and zero stock at minimum price is the most expensive mistake available to a capital allocator, and Mohawk made it in consecutive cycles.

The counter-evidence deserves fair statement. The Q2 2026 repurchase — 0.6m shares for $60.0m, an average near $100 — was executed close to the 19 May 2026 low of $94.33. That is genuinely countercyclical behaviour and, per the monthly disclosure, the right instinct. One quarter does not reverse the record, but it is the first evidence in years that price sensitivity is entering the process. Whether it survives the transition to a new CEO is one of the more interesting open questions on this name.

7.2 M&A and the impairment verdict

Cash paid for acquisitions: FY2018 $569.0m, FY2019 $81.1m, FY2021 $124.0m, FY2022 $209.6m, FY2023 $515.4m, FY2025 $6.9m.

The verdict on that programme, and on the larger deals preceding it, arrived as impairment:

$1,573.5m written off in two years, spread across all three segments. This is the critical detail: an impairment concentrated in one segment is a bad deal, and every acquirer has one. An impairment of this magnitude taken simultaneously across every segment is a systematic error — evidence that Mohawk consistently paid prices its assets could not earn back, in a business whose through-cycle returns never supported acquisition multiples. Goodwill and intangibles still stand at $1,983.5m, so the exposure is not fully retired.

Set against this, the write-offs total roughly 19% of today’s market capitalisation and roughly the entire cumulative acquisition spend of 2018–2023.

7.3 Reinvestment

Capital expenditure: $794.1m (2018), $545.5m (2019), $425.6m (2020), $676.1m (2021), $580.7m (2022), $612.9m (2023), $454.4m (2024), $440.0m (2025), ~$460m planned for 2026. Against FY2025 depreciation of $652.6m, current spending is 67% of depreciation.

The 2018–2023 investment was substantially LVT and ceramic capacity — the categories that are now oversupplied. Mohawk added capacity into the top of a capital cycle, which Marathon’s framework identifies as the reliable precursor to poor forward returns, and the subsequent ROIC path confirms it. The current sub-depreciation spend is the correct response to that mistake, but it is the response of a business in retrenchment, not one compounding.

7.4 Restructuring

The newly announced programme targets ~$60m of annual savings for ~$50m of cash restructuring cost, most complete by end-2027, focused on “operational simplification, organizational realignment, warehouse consolidation and capacity optimization.” Prior programmes contributed $43m of benefit in Q2 2026 and $21m in Flooring NA and $20m in Global Ceramic at the segment level.

The programme-level savings are real. The consolidated result is what matters, and consolidated operating margin fell from 6.40% to 4.54% between FY2024 and FY2025 while prior restructuring was delivering. The unavoidable inference is that savings are either not permanent or are being handed to customers in price. Management’s characterisation — “permanent structural improvements to our cost base, not temporary measures” — is a claim the multi-year margin record contradicts, and it should be tested against consolidated margin, not against programme-level savings tallies.

7.5 Incentives, compensation and the clawback

The 2026 proxy identifies the most important 2025 compensation measures as Adjusted EPS, TSR relative to the S&P 500, and Adjusted Operating Income. Adjusted EPS as reported by the company: $14.86 (2021), $12.85 (2022), $9.19 (2023), $9.70 (2024), $8.96 (2025).

Two problems. First, FY2025 adjusted EPS of $8.96 sits against GAAP diluted EPS of $5.93 — a $3.03 gap, 34% of the adjusted number. Paying primarily on Adjusted EPS at a company that took $1.57bn of impairments in two years rewards management on a measure that excludes precisely the consequence of the capital-allocation decisions being judged. The inclusion of relative TSR is appropriate and mitigates this, but it did not prevent PEO compensation actually paid of $4,806,094 in FY2025.

Second, and more serious, the proxy discloses that following the FY2025 revision of the 2023 and 2024 financial statements, Mohawk determined that erroneously awarded compensation had been paid under the 2023 and 2024 SEAIP, MAIP, LTIP and EEIP plans, requiring recovery under the Clawback Policy. The relative TSR metric was unaffected. The proxy extract reviewed does not quantify the recovered amount.

The company’s own pay-versus-performance disclosure is the most damning single table in the filings:

Over the five-year measurement window a shareholder lost 22.5% while the peer group gained 68.3% — a 91-percentage-point shortfall, disclosed by Mohawk itself.

7.6 Insider behaviour and ownership

The Lorberbaum family retains substantial ownership: Jeffrey S. Lorberbaum beneficially owns 10,078,475 shares (16.5%) as of 27 March 2026, including 8,132,685 held through Aladdin Partners, L.P. (13.3%). All directors and executive officers as a group hold 17.9%. BlackRock holds 9.9% and Dimensional 5.1%. Incoming CEO Paul De Cock held only 45,216 shares.

The transaction record is the finding. Across 99 Form 4 filings since 1 January 2025 there is not a single open-market purchase (code P). Every transaction is a sale, a tax-withholding on vesting, a grant, or an administrative disposition. Nineteen months — a window containing a 33% drawdown to $94.33 — produced zero discretionary buying by the people who know the asset best.

In the week following the Q2 print, insiders sold into the rally: Jeffrey Lorberbaum across MCL Family Funds Trust, Dalton Fund, JSL Legacy Fund LP and direct holdings at $130.26–$132.91 on 3 August; Suzanne L. Helen 7,000 shares at $131.52; David Lee Repp 225 shares at $130.59; Bernard Thiers 13,393 shares at $134.98 on 5 August.

Fair treatment requires two caveats. Every one of those sales was executed under a pre-existing Rule 10b5-1 plan, which materially reduces their signal value — these are scheduled diversification decisions, not timed judgements on value. And a family already holding 16.5% has a legitimate diversification need that a non-owner executive does not. The informative datum is therefore not the selling; it is the complete absence of buying.

7.7 Verdict

Management has not allocated capital intelligently, and the company’s own disclosures prove it. The evidence chain: $900.3m of repurchase at the 2021 peak and zero at the 2023 trough; $1,573.5m of impairment across all three segments retiring a decade of acquisition premia; capacity added into the top of a capital cycle; a five-year TSR 91 points behind the peer group; and a clawback of incentive compensation following a restatement. Against that: a strong balance sheet maintained throughout, negligible dilution, meaningful share-count reduction, and one genuinely well-timed repurchase in Q2 2026. The balance is clearly negative. The single most important forward question on this name is whether the incoming CEO changes the capital-allocation process or inherits it — and on that, the proxy tells us he owns 45,216 shares and the outgoing CEO remains Chairman.

8. Changes and Headwinds — Last Two Years

8.1 Leadership transition

Announced 11 June 2026 via 8-K: Paul F. De Cock, 53, becomes CEO and a director effective 30 September 2026, succeeding Jeffrey S. Lorberbaum, who retires as CEO after 25 years and continues as Chairman of the Board. De Cock’s compensation is set at a base salary of $1,267,000 with a target annual bonus of 125% of salary.

De Cock is an internal, long-tenured appointment: he joined through the 2005 Unilin acquisition, ran Unilin North America (2006–08), Unilin Flooring (2008–18), Flooring North America (November 2018 – February 2025), then President and COO from February 2025 and interim President of Flooring Rest of the World from February 2026. The transition was clearly planned — the COO role was created for it a year in advance.

Interpretation. Continuity is the appropriate word. This is a deep operator who knows every segment, and the announcement was received positively (+7.47% on 11 June). But three points temper it. Lorberbaum remaining Chairman, with 16.5% of the stock, means the strategic and capital-allocation posture that produced the record in the relevant section retains board control. De Cock ran Flooring North America from 2018 to 2025 — the segment whose operating margin was 3.12% in FY2025. And his personal shareholding of 45,216 shares is modest for an incoming chief executive.

8.2 The FY2025 deterioration and FY2026 inflection

FY2025 was the trough: revenue −0.5% to $10,785.4m, operating income down from $693.5m to $489.8m, operating margin from 6.40% to 4.54%, ROIC from 5.31% to 3.69%. Flooring North America’s segment margin halved from 6.30% to 3.12%.

H1 2026 has inflected: revenue +7.4% to $5,720.1m, operating income +28.3% to $365.5m, operating cash flow more than doubled to $426.6m, free cash flow $236.0m. Q2 alone delivered 34.4% operating-income growth with every segment expanding.

Whether this is an inflection or a favourable quarter is the central live question. The evidence for “favourable quarter”: $0.63 of non-recurring tariff refunds, customer pre-buying ahead of price increases, initial stocking of new placements, and management’s own guide to a more-pronounced-than-normal sequential decline with a further $35m of sequential inflation.

8.3 Input-cost inflation and the conflict

Management referenced a Middle East conflict repeatedly as a driver of energy and materials inflation, particularly acute in Europe where “inflation is running well ahead of other regions.” Underlying inflation was $77m in Q2 2026, with a similar ~$35m sequential step-up expected into Q3 and Q4 “elevated.” Mohawk hedges only “a portion of our near-term requirements” of natural gas.

Multiple price increases have been executed across products and geographies, with more possible. Management expects price, mix and productivity to offset inflation for the full year — a claim that has held so far but which depends on competitors raising price in parallel in an oversupplied market.

8.4 Trade policy

Two developments, both currently favourable. Tariff refunds delivered ~$0.63 per share in Q2 2026 with ~$0.12 guided into Q3 — reversals of costs previously absorbed. Countertops: the ITC has proposed minimum tariffs of 25%, with a Presidential decision pending; Mohawk has commissioned a second US line to capture the benefit.

Both are policy-dependent, reversible, and — in the refunds’ case — explicitly non-recurring.

8.5 Balance-sheet and governance actions

• 12 May 2026: new $1.5bn unsecured revolving credit facility (JPMorgan Chase / J.P. Morgan SE), replacing the October 2019 facility. Prudent, timely refinancing at a moment of balance-sheet strength.
• 21 May 2026: shareholders approved the 2026 Incentive Plan, reserving 3,500,000 shares.
• Q4 2025 / February 2026: the accounts-receivable and intercompany restatement and consequent clawback (the relevant section, the relevant section).
• FY2025: general corporate expense nearly doubled to $103.4m from $58.5m, unexplained at segment level.

8.6 Verdict

Net neutral-to-negative for the thesis, with the balance of evidence favouring “not yet resolved.” The strengthening items are genuine: an inflecting H1, a well-planned CEO succession, a refinanced balance sheet, and trade policy running Mohawk’s way. The weakening items are structural: a restatement with a clawback, a doubling of unexplained corporate expense, an accelerating input-cost curve into the second half, and a CEO transition that leaves the prior capital-allocation authority in the chair. Critically, nothing in the last two years has changed the competitive position or the returns structure — Mohawk still earns half its cost of capital, still has no moat, and still operates in an oversupplied industry. What has changed is the price, which has risen 44% in three months.

9. Risk Analysis

Catastrophic-loss risk is low. With net debt at 0.8× EBITDA, $849.6m of cash, a fresh $1.5bn revolver and consistently positive free cash flow, the probability of permanent capital impairment through insolvency is remote. The realistic downside is not zero — it is a multi-year grind at a sub-cost-of-capital return with the shares oscillating in the range they have occupied since 2022, which on a five- and ten-year view has already cost owners 6.9% and 4.2% per annum respectively.

The two risks that dominate are #1 and #2, and they are not independent: the bull case requires housing turnover to recover and the recovery to accrue to manufacturers rather than being competed away by idle capacity. Both must be true. The stock at $136 prices both as though they are.

10. Valuation Discussion

No price target and no recommendation appears in this section. What follows is embedded-expectations and scenario analysis only.

10.1 Building the enterprise value correctly

ROIC.ai’s enterprise-value row for the quarter ended 30 June 2026 is unusable: it returns a market capitalisation of $7,340,465,000 with every balance-sheet field null, so its reported enterprise value simply equals a stale quarter-end market cap with no debt bridge. The bridge was therefore rebuilt from the filings at the 7 August 2026 close:

10.2 Trailing multiples

LTM figures through 4 July 2026, computed as FY2025 less H1 2025 plus H1 2026:

EBITDA is built from operating income plus D&A rather than accepted from the ROIC.ai feed, which derives EBITDA from pre-tax income and therefore corrupts any year containing impairments — a material distinction for a company that has taken $1.57bn of them.

10.3 Own-history context — and a necessary correction

The AZI valuation index for 7 August 2026 reports a P/E of 20.46× at the 85.5th percentile of Mohawk’s own multi-year history, P/B of 1.0018× at the 40.7th, P/S of 0.7705× at the 42.0th, and a composite at the 56.1st.

The snapshot’s fundamental inputs are stale by a quarter and must be corrected. Reverse-engineering: book value per share of 135.8136 × 60.5m shares = $8,217m, which reconciles to the 31 December 2025 equity of $8,373.3m, not to the 4 July 2026 equity of $8,540.7m. And trailing EPS of 6.651 × ~61m = ~$406m against an actual LTM net income of $464.1m. Only the price is current.

Corrected, the trailing P/E falls from 20.46× to ~17.98× and P/B from 1.0018× to ~0.96×. The direction of the headline survives — Mohawk still trades in the upper reaches of its own ten-year earnings multiple — but the 85.5th percentile overstates it, and the honest characterisation is “upper-middle of its own range on depressed earnings.”

That split is the entire valuation story. Mohawk is simultaneously cheap on assets (0.96× book, 40th percentile) and expensive on earnings (~18× trailing, upper range) — which is exactly what a cyclical looks like at a trough in earnings. The question is which denominator is right.

Peer own-history composites for context: Floor & Decor 13.1st percentile, Fortune Brands 53.9th, Mohawk 56.1st, Masco 73.8th, Armstrong World 77.6th, Sherwin-Williams 77.9th, Interface 81.4th, Owens Corning 91.6th. Relative to its own peer set, Mohawk is not the expensive name — most building-products comps sit far higher in their own ranges. On an asset basis Mohawk is the cheapest liquid way to own a flooring recovery, and that is a legitimate observation that the bear case must accommodate.

10.4 Embedded expectations — what the price requires

This is the most useful lens on a cyclical, because it converts a multiple into an operating requirement.

At an enterprise value of $9,297.5m and an estimated WACC of 9.5%, Mohawk must generate approximately $883m of NOPAT to earn its cost of capital. At a 21% tax rate that implies EBIT of roughly $1,118m, which on LTM revenue of $11,177.6m is an operating margin of 10.0%.

Mohawk’s trailing operating margin is 5.10%. It has achieved 10%+ in exactly two of the last ten years — 2018 (10.97%) and 2021 (11.92%) — both demand-boom years, plus 2016–17 at 14.3% under a materially different cost and competitive structure.

Put differently: buying at $136 underwrites approximately a doubling of operating income to peak-cycle levels, simply to earn the cost of capital. At the ten-year median operating margin of roughly 8%, EBIT would be ~$894m and NOPAT ~$706m — a 7.6% return on today’s enterprise value, still below the cost of capital. The market is not pricing normalisation; it is pricing a return to peak.

What the market may be pricing correctly: the cyclical trough in housing turnover is genuine and temporary; the balance sheet is strong enough to wait; free cash flow is robust; and the asset base at 0.96× book provides a floor of sorts.

What the market may be pricing incorrectly: that the tariff refunds and Q2 pre-buy represent a run-rate; that restructuring savings will drop to the consolidated line rather than being competed away; and — most importantly — that a volume recovery in an industry with un-rationalised capacity converts to peak-cycle margins. History says it converts to volume without price.

10.5 Scenario analysis

Assumptions stated explicitly. Mid-2029 horizon; ~60.5m shares (no material buyback or issuance assumed); net debt held at $1,062m; exit multiples stated per scenario. These are illustrative, not forecasts.

The distribution is wide — roughly −23% to +75% — and it is dominated by a single variable management does not control: housing turnover. That is the definition of a cyclical rather than a compounder, and it is why the entry price carries more weight here than the business analysis. Note also that even the base case requires a 7.0% operating margin, which Mohawk has not achieved since 2021.

10.6 A note on annualising the current quarter

Q2 2026 adjusted EPS of $3.67 annualises to $14.68, which against $136.06 implies 9.3× earnings — superficially very cheap. That arithmetic is wrong twice over: $0.63 of the quarter was non-recurring tariff refunds, and Q2 is seasonally the strongest quarter with management explicitly guiding to a more-pronounced-than-usual sequential decline and a Q3 baseline of $2.38–$2.48. Four quarters at the Q3 baseline run-rate would be roughly $9.50–$9.90 of adjusted EPS, or 13.7×–14.3× — and adjusted EPS itself sat $3.03 above GAAP in FY2025.

10.7 Verdict

Cheap on assets, expensive on earnings, and the earnings denominator is doing all the work. At 0.96× book with a 7.5–9.9% free-cash-flow yield and a 0.8× levered balance sheet, Mohawk is demonstrably not expensive on a liquidation or replacement basis, and it is the cheapest peer on an own-history basis in a group trading at 74th–92nd percentiles. But book value in a business earning 4.7% on invested capital is not worth book — the assets are worth what they earn, and they earn about half the cost of capital. The embedded-expectations arithmetic is the clearest statement available: at $136 the market requires a 10% operating margin, achieved twice in ten years, merely to break even against the cost of capital. The valuation is defensible only on the assumption that the current earnings are a trough — which they probably are — and that the recovery accrues to the manufacturer — which the industry structure argues against.

11. Variant Perception

11.1 What consensus believes

The consensus view embedded in the +44% three-month move appears to be: Mohawk is a quality global franchise at a cyclical trough; housing turnover at 30-year lows must normalise; Q2 2026 demonstrated the operating leverage and the share gains; the restructuring is delivering; a new CEO brings fresh energy; the balance sheet is unlevered; and at roughly book value the downside is protected.

Most of the individual components are factually correct. The synthesis is what is questionable.

11.2 The strongest bull case

Stated at its strongest, because it deserves to be:

Housing turnover is at a 30-year low, which is a mean-reverting variable, not a permanent state. US and European interest rates have fallen to their lowest since autumn 2022. Deferred flooring replacement accumulates as an obligation, not a lost sale — every year of deferral builds the eventual pool. Mohawk is the highest-operating-leverage way to own that recovery: a heavy-fixed-cost manufacturer with capacity already in place and capex running below depreciation, so incremental volume drops through at very high margins. The Q2 2026 print is evidence the machine works — 34% operating-income growth on 6.8% revenue growth is roughly 5× operating leverage, and Flooring NA’s margin nearly doubled.

Meanwhile the balance sheet is pristine (0.8× net debt to EBITDA, $849.6m cash, a fresh $1.5bn revolver), the company generates $616m–$811m of annual free cash flow, the share count has fallen 17% in eight years with no dividend obligation, and the stock trades at 0.96× book — the 40th percentile of its own history, against peers at the 74th–92nd. Trade policy is currently a tailwind. And the incoming CEO has a fresh mandate with a strong balance sheet, having just demonstrated countercyclical repurchase discipline at the May low.

If housing turnover normalises and Mohawk holds price, the base case is ~$173 and the bull case ~$238.

11.3 The strongest bear case

The bear case does not require housing to stay depressed. It requires only that the recovery be competed away.

Mohawk earns 4.7% on invested capital. It has averaged roughly 6% for a decade against a ~9.5% cost of capital. Over ten years it has compounded shareholder capital at negative 4.2% per annum with a 79% drawdown, and it is the only negative performer in its own peer set. Gross margin has fallen 753bp since 2017 and has not structurally recovered through a full inflation-and-disinflation cycle — the definitive signature of a price-taker without a moat. The 10-K concedes import pressure and surplus regional capacity; LVT has matured; and no industry capacity closure is visible, which under Marathon’s framework means returns stay suppressed until capital exits, regardless of demand.

Capital allocation compounds the problem: $900.3m repurchased at the 2021 peak, zero at the 2023 trough, $1,573.5m impaired across all three segments, and a five-year TSR 91 points behind the peer group by the company’s own disclosure. A restatement triggered a clawback of 2023–24 incentive compensation. And not one insider bought a share on the open market in nineteen months, including at $94.

At $136, the market requires a 10% operating margin — achieved twice in ten years — merely to earn the cost of capital, on earnings currently flattered by $0.63 per share of non-recurring tariff refunds and by customer pre-buying that management concedes borrowed from Q3.

11.4 The variant perception

Where I think consensus is offsides is on framing, not on facts. The market is treating Mohawk as a quality franchise at a cyclical trough. The evidence says it is a structurally sub-cost-of-capital manufacturer in an oversupplied industry, at a cyclical trough. Those two descriptions produce very different fair values from identical trough earnings, because they imply different mid-cycle margins — the first says 10%+, the second says 7% or less.

The factor model provides the decisive independent evidence for this reframing. Despite being +32% in three months and +44% off the May low, Mohawk’s Momentum loading is approximately zero (+0.03 to +0.04). If the market were genuinely re-rating the business on improving fundamentals, that would show as a positive momentum loading. Instead the loadings show Market +1.44, Industry Home Construction +1.16, SmallSize +0.71, Value +0.40, InterestRate −0.25, CreditRisk −0.28, Growth −0.09, with an R² of 0.650. Translated: this move is beta. Mohawk has been carried up by a housing-and-rates rally, exactly as its factor loadings dictate it must be, and the +14.70% single-session move on a 2022 CPI print tells you the same thing about what actually drives this equity.

That matters for positioning because it means the recent strength contains no information about Mohawk specifically. The stock is where it is because rates fell and housing-linked assets rallied, not because the market has concluded anything about the moat, the returns, or the new CEO. Consensus may be conflating a factor move with a fundamental verdict.

The second variant point concerns the asset-value floor. The bull case leans on 0.96× book as downside protection. But book value is only a floor if the assets are worth book, and assets earning 4.7% against a 9.5% cost of capital are, on a discounted-cash-flow basis, worth materially less than their carrying value. Mohawk has already demonstrated this: it wrote off $1,573.5m — roughly 19% of today’s market capitalisation — in 2022–23 precisely because carrying values exceeded recoverable amounts. There is still $1,983.5m of goodwill and intangibles on the balance sheet. “Trades at book” is a comfort only if book is real, and the company’s own impairment history is evidence that it periodically is not.

11.5 The 3–5 assumptions that matter most

1. Housing turnover normalises within three years from 30-year lows. (Bull requires; bear does not deny.)
2. The recovery converts to price, not just volume — i.e. industry capacity rationalises or demand outruns it. (This is the crux.)
3. Restructuring savings reach the consolidated line rather than being competed away — testable quarterly.
4. Mid-cycle operating margin is ≥8%, versus 5.10% trailing and a ten-year median near 8% achieved under an easier competitive structure.
5. Capital allocation improves under the new CEO — specifically that the 2021-style peak repurchase is not repeated and that any M&A clears a return hurdle.

11.6 Falsifying evidence for each side

Would falsify the bear case: two or more consecutive quarters of consolidated operating-margin expansion that survives stripping out tariff refunds, with Flooring North America sustaining an 8%+ segment margin; announced capacity closures by Mohawk’s ceramic or LVT competitors; a return on invested capital above 8% in any twelve-month period; or sustained insider open-market buying.

Would falsify the bull case: housing turnover recovering measurably — existing home sales up 15%+ from trough — while Mohawk’s incremental operating margins come in below 20%; gross margin failing to exceed 26% on a full-year basis; a large debt-funded acquisition; or a resumption of buybacks above $140 while ROIC remains below 6%.

12. Fact vs. Interpretation

13. Open Questions

1. Why did general corporate expense nearly double, from $58.5m in FY2024 to $103.4m in FY2025? The 10-K provides no segment-level bridge. Is this the SAB 108 cumulative correction, and if so how much? If not, what is the recurring run-rate?
2. What dollar amount of incentive compensation was recovered under the clawback, from which executives, and what remediation was made to the intercompany reconciliation controls that failed for three years?
3. What is the organic revenue growth rate, excluding acquisitions and currency, for each of the last five years by segment? Mohawk does not disclose a clean organic bridge.
4. What third-party data supports the claimed share gains in hard and soft surfaces in Flooring North America and “most regions” globally?
5. What is management’s mid-cycle operating-margin target by segment, and what specifically bridges Flooring North America from 3.12% (FY2025) to that target?
6. Will capital expenditure return to or above depreciation, and if not, what is the maintenance capital requirement of a $4.6bn net PP&E base?
7. Under the new CEO, will the buyback be price-disciplined? The Q2 2026 purchases near $100 were well-timed; the Q3 pace at $130+ will be the tell.
8. What is the remaining Russia exposure — revenue, assets, and the carrying value of Kerama Marazzi?
9. How much of the $60m restructuring benefit will reach consolidated operating margin rather than being competed away in price, and over what period?
10. What is the exposure if the countertop tariff is not granted, given a second US line has already been commissioned?
11. How much of Q2’s volume was genuine sell-through versus channel stocking? Management conceded it “cannot precisely quantify” the pre-buy.
12. What return hurdle will the new CEO apply to acquisitions, given the 2022–23 impairment history and his statement that opportunities “need to achieve our financial return criteria”?

14. What Must Be True

14.1 For the bull case

1. Housing turnover recovers meaningfully within roughly three years. US existing home sales rise materially from 30-year lows as affordability improves with rates.
   • Falsification test: if US existing home sales have not risen at least 15% from the trough by mid-2028, the demand leg has failed.
2. The volume recovery converts to margin, not just revenue. Incremental operating margins on recovered volume must exceed roughly 20% to lift consolidated margin toward 8%+.
   • Falsification test: in any four consecutive quarters where revenue grows 5%+ year-over-year, if the incremental operating margin (Δ operating income ÷ Δ revenue) is below 20%, the recovery is being competed away.
3. Restructuring savings reach the consolidated line. The ~$60m programme plus prior programmes must show up in reported margin.
   • Falsification test: if FY2027 consolidated operating margin, excluding tariff refunds, is below 6.5%, the savings are not sticking.
4. Capital allocation improves under De Cock. No repeat of the 2021 peak-price buyback; no large acquisition below the cost of capital.
   • Falsification test: aggregate repurchases above $300m executed at an average price above $150 while trailing ROIC remains below 7%.
5. Gross margin structurally recovers. Toward 26–27% on a full-year basis, versus 23.87% in FY2025.
   • Falsification test: FY2027 full-year gross margin below 25.5%.

14.2 For the bear case

1. Industry capacity does not rationalise, so price stays capped even as volume recovers.
   • Falsification test: announced permanent closures by named ceramic or LVT competitors totalling a meaningful share of regional capacity, or two consecutive quarters in which Mohawk’s realised price/mix contribution exceeds its underlying inflation by more than $50m.
2. ROIC remains structurally below the cost of capital. The ten-year average of ~6% persists.
   • Falsification test: trailing-twelve-month ROIC above 8% in any period through 2028.
3. Margins do not structurally recover because the 753bp gross-margin decline reflects permanent competitive erosion rather than cyclical under-absorption.
   • Falsification test: full-year gross margin above 27% in any year through 2028.
4. Current earnings are flattered by non-recurring items — tariff refunds and channel pre-buy — and normalise downward.
   • Falsification test: H2 2026 adjusted EPS, excluding tariff refunds, exceeding H2 2025 adjusted EPS by more than 15%.
5. Capital allocation does not change because the outgoing CEO remains Chairman with 16.5% of the stock.
   • Falsification test: a publicly stated return hurdle for M&A and repurchase, or a formal capital-allocation framework disclosed with quantified thresholds, within twelve months of the transition.

14.3 The single decisive variable

If forced to one test: the incremental operating margin on recovered volume. Everything else — the trough, the balance sheet, the book value, the new CEO — is either agreed by both sides or second-order. The bull case and the bear case make an identical prediction about revenue and opposite predictions about what revenue converts to. The first four consecutive quarters of genuine volume recovery will settle it, and the metric is observable from the reported segment tables without relying on any management adjustment.

15. Source Appendix

See Appendix B below for the full source list with URLs and access dates.

This article contains no buy or sell recommendation and no price target in Sections 1 through 15. The single exception is the clearly labelled Claude's Take block at the top, which is the author’s own independent opinion. General information only, not investment advice. Published 2026-08-08.

APPENDIX A — Standard Diligence Questionnaire

Mohawk Industries, Inc. (NYSE: MHK) — 2026-08-08

Supplemental to the main analysis. Answers are labelled Fact / Interpretation / Assumption where the distinction matters.

General

What thoughtful questions have other investors asked about this company?

The sell-side questions on the Q2 2026 call were unusually well-targeted and cluster on four themes, each of which is the right question.

How much of Q2 was borrowed from Q3? John Lovallo (UBS) and Stephen Kim (Evercore ISI) both pressed hard on why outperformance would not carry forward, with Kim pinning management to the historical ~4.5% Q2-to-Q3 sequential decline and asking whether the drop would exceed it. Management confirmed it would likely be “a little more pronounced than normal.” (Fact.) Matthew Bouley (Barclays) pushed for quantification of the pre-buy; management conceded it “cannot precisely quantify that” and has “no visibility on the inventory position of our customers.”

Can price be pushed in a soft market? Sam Reid (Wells Fargo) and Brian Biros (TRG) asked directly about the market’s appetite for further pricing and about competitor rationality. Management’s answer — “with costs rising as much as they have, the whole industry really needs to take pricing to cover them” — is a statement about industry necessity, not about Mohawk’s pricing power. (Interpretation: this is the language of a price-taker.)

What does the new CEO change? Susan Maklari (Goldman Sachs), Rafe Jadrosich (BofA) and Phil Ng (Jefferies) all probed the transition, with Ng specifically asking whether buybacks would be “more opportunistic or more regimented.” De Cock declined to elaborate beyond “share repurchases will remain an important part of our capital allocation policy” — a non-answer to the most important capital-allocation question on the name. (Fact.)

Is there category share shift? Adam Baumgarten (Vertical Research) and Mike Dahl (RBC) asked about LVT/laminate excess capacity and substitution. Management conceded LVT “is becoming a more mature category.”

The question the analysts did not ask, and which matters most: why has return on invested capital averaged roughly 6% for a decade against a cost of capital near 9.5%, and what specifically changes that?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Cyclical low, clearly. (Fact-based interpretation.) FY2025 operating margin of 4.54% compares with a ten-year range of 4.54%–14.29%; ROIC of 3.69% against a range of 0.31%–11.78%. The demand driver is at an extreme: US existing home sales at roughly a 30-year low, with the 10-K describing turnover “near historically low levels” and management calling the resale market “near multi-decade lows.” Trailing operating margin has since improved to 5.10%. There is no reasonable reading in which these are peak earnings.

Driven by the external environment or internal actions? Overwhelmingly external. Housing turnover, new-construction starts, energy prices and import competition explain the earnings path far better than anything Mohawk did. The factor model confirms it quantitatively: a Market loading of +1.44 and a Home Construction industry loading of +1.16 with an R² of 0.650, and a share price that moved +14.70% in one session on a 2022 CPI print. Internal actions — restructuring, mix, product placement — are real and are worth roughly $43m per quarter at present, but they have not prevented consolidated margin from falling from 6.40% to 4.54%. (Interpretation: management is playing a weak hand competently.)

How stable are revenues? Moderately stable in aggregate, highly unstable in profit. Revenue ranged $9,552m–$11,737m over the last six years, a ±10% band — but operating income over the same span ranged from −$291.9m to $1,335.0m. That is the signature of a high-fixed-cost manufacturer: revenue moves modestly, earnings move violently. There is no recurring revenue of consequence; the only annuity-like line is Unilin intellectual-property licensing, disclosed only inside an aggregated “Other” category of $1,078.2m (10.0% of FY2025 revenue) that also contains roofing elements, insulation boards and chipboards.

Outlook for products/services? Mature across the board. Ceramic is flat-to-modestly-recovering; carpet is in structural secular decline as hard surfaces take share; laminate and wood are stable; LVT — the growth engine of 2018–2023, whose US share rose from ~17% to ~26% between 2022 and 2023 — has, on management’s own admission, converged to industry growth. (Interpretation: the mix-shift growth story that justified heavy LVT capital investment has expired, and the capacity remains.)

How big will this market be — growing, shrinking, domestic or international? The US flooring market was roughly $117bn in 2025 and is projected at ~$124bn in 2026. Growth is essentially GDP-and-housing-linked — low single digits through a cycle, with no secular tailwind. Mohawk is genuinely international: 53.2% of Q2 2026 revenue from the United States, 32.9% Europe, 6.7% Latin America, 7.1% other, with manufacturing in 19 countries and sales into ~180. The international footprint is a diversifier of demand but an amplifier of cost risk — European natural gas is the single most acute input exposure, and management notes European inflation “running well ahead of other regions.”

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More. Three converging forces: global ceramic and LVT capacity built through 2018–2022 has not been rationalised; the 10-K concedes that “certain regions around the world have established sufficient capacity to allow them to meet domestic needs” and export the surplus; and LVT’s maturation removes the growth cushion that previously absorbed new capacity. The only offsetting force is trade protection — tariffs on imports and the proposed 25% ITC countertop minimum — which is policy-dependent and reversible. (Interpretation.)

How profitable is the business (ROIC, ROE)? Poor, and deteriorating. FY2025 ROIC 3.69% (feed) / 3.87% (recomputed); LTM through 4 July 2026, 4.69%, or 5.91% excluding goodwill and intangibles. FY2025 ROE 4.66%, down from 17.50% in 2016. Ten-year ROIC path: 11.78% (2016) → 3.69% (2025). Against an estimated WACC of ~9.5%, Mohawk earns approximately half its cost of capital. This is the single most important fact about the business.

How profitable is the industry — how many competitors, what barriers to entry? The industry is fragmented and structurally unprofitable at the manufacturing layer. Competitors include Shaw (Berkshire Hathaway), Tarkett, Interface, and a very long tail of Chinese, Indian, Turkish, Spanish, Italian and Brazilian ceramic producers. Barriers to entry are low-to-moderate: capital intensity is the only meaningful barrier, and it has repeatedly failed to deter entry because capacity is fungible across geographies and can be exported. The market has rendered its own verdict on where the profit pool sits — Floor & Decor, a specialty retailer with no manufacturing, trades at 2.77× book and 34× earnings; Mohawk, which owns the kilns, trades at 0.96× book. (Interpretation.)

Can the business be easily understood? Yes. This is a considerable virtue and should be credited. Mohawk makes flooring, sells it through distribution and retail, and earns a margin over materials, energy and conversion cost. There is no financial engineering, no off-balance-sheet complexity, no opaque revenue recognition. The accounting is conventional. The complexity is geographic (19 countries, multiple currencies) rather than conceptual — and it was precisely that geographic complexity that produced the intercompany accounts-receivable error corrected in FY2025.

Can it be undermined by foreign low-cost labour? Yes, and it demonstrably is. This is not a hypothetical risk; it is the operative competitive dynamic. The 10-K explicitly cites pressure “from imported ceramic products.” Ceramic tile and LVT are both readily shippable relative to value, and low-cost producers in Asia, Turkey and Latin America compete directly. Freight cost and tariffs are the only natural protection, which is why trade policy has become materially relevant to the earnings profile. Carpet is more protected — bulky, low value-density, and increasingly domestic — but it is also the segment in secular decline and earned a 3.12% margin in FY2025.

Do brands matter? They matter for shelf space, not for price. Daltile, Marazzi, American Olean, Karastan, Pergo, Quick-Step, Godfrey Hirst, Moduleo and Unilin are genuinely recognised names that earn specification and retail placement. But the test of a brand moat is whether removing it would deteriorate a financial outcome — and gross margin has fallen 753bp since 2017 while the brands remained. (Interpretation: brand here is a distribution asset, not a pricing asset.)

What is the nature of competition? The 10-K states competition is “on the basis of performance, quality, style and service, rather than price.” (Interpretation: this is a self-description that the gross-margin path contradicts. In a business where the marginal producer is frequently an importer with a lower energy and labour cost base, price is set at the margin regardless of how the incumbent characterises the basis of competition. Management’s own Q2 call language — that the industry “needs to take pricing to cover” costs — is the more honest description.)

Customers’ switching costs? Effectively zero. Flooring is selected from samples at point of sale, roughly once a decade for a consumer and on a seven-to-twelve-year refit cycle for a commercial customer. A retailer can substitute a competing SKU without penalty; a builder can re-specify between projects. There is no installed base, no integration, no data lock-in, no contractual stickiness. The nearest thing to a switching cost is a retailer’s investment in Mohawk display fixtures and sample sets — a genuine but modest friction, and one Mohawk pays for through its own capitalised costs to obtain contracts ($66.1m at 4 July 2026).

Financial Condition & Balance Sheet

Assets not fully recognised on the balance sheet? Two candidates. The Unilin intellectual-property estate — laminate locking-system patents licensed to third-party manufacturers — generates high-margin royalty income disclosed only within the aggregated “Other” line; its carrying value almost certainly understates its economic value. The brand portfolio is carried at $691.1m of tradenames after impairment, which given the recognition of names like Daltile and Pergo may be conservative — though the 2022–23 impairments suggest management has, if anything, been slow rather than quick to write down. Against these, property, plant and equipment is carried at $4,603.6m net against $11,036.3m gross — 58% depreciated — so replacement cost of the productive asset base substantially exceeds carrying value. (Interpretation: this is the strongest form of the asset-value argument, and it is a real one — though replacement value is only relevant if the assets earn a return, and at 4.7% ROIC they do not.)

Off-balance-sheet liabilities? Nothing material identified. Operating leases are capitalised on balance sheet — right-of-use assets $425.3m, current lease liabilities $120.0m, non-current $322.2m. Commitments and contingencies are disclosed in Note 15 with routine litigation language; no individually material legal matter was identified in the Q2 2026 10-Q review. Pension obligations are not separately flagged as significant. No off-balance-sheet financing structures, securitisations or guarantees of consequence were found.

How conservative is the accounting? Mixed, with one genuine flag. The conservative side: impairments were taken decisively in 2022–23 ($1,573.5m) rather than deferred; depreciation of $652.6m in FY2025 substantially exceeds capital expenditure of $440.0m; there is no aggressive revenue recognition; and stock-based compensation of $30.0m is a rounding error. The flag: during Q4 2025 Mohawk identified an intercompany error affecting accounts receivable that had gone undetected for at least three years, reducing receivables by $42.1m, cutting 2023 net earnings by $9.5m and 2024 by $3.0m, and reducing 31 December 2022 retained earnings by $29.6m. It was material enough on a cumulative basis to require revision under SAB 108 and to trigger a clawback of 2023–24 incentive compensation. Management concluded disclosure controls remained effective. Separately, general corporate expense nearly doubled to $103.4m in FY2025 without a segment-level explanation. (Interpretation: small in dollars, non-trivial in what it implies about a 19-country control environment. It warrants closer-than-average monitoring, not alarm.)

How CapEx-hungry is the business? Very. Capital expenditure over 2018–2025 totalled roughly $4.1bn against cumulative net income well below that. Capex ran $794.1m (2018), $545.5m (2019), $425.6m (2020), $676.1m (2021), $580.7m (2022), $612.9m (2023), $454.4m (2024), $440.0m (2025), with ~$460m planned for 2026. The recent figures are running at only ~67% of depreciation ($440.0m against $652.6m in FY2025), which is a harvest posture: it flatters free cash flow and is defensible in a downturn, but it is inconsistent with management’s stated “invest in the business first” priority and cannot persist indefinitely. (Open question: what is true maintenance capex on a $4.6bn net PP&E base?)

Capital Allocation & Management

How much FCF does the business generate, how does management use it, what is the philosophy? Free cash flow was $616.2m in FY2025, $679.5m in FY2024, $716.3m in FY2023, and $811.5m on a trailing basis through 4 July 2026 (the last flattered by a $171.0m working-capital release). Cash conversion consistently exceeds net income, at 1.3–1.8×.

Uses, in order: capital expenditure (~$440–460m/yr), then share repurchase, then debt reduction. There is no dividend and never has been. The stated philosophy from the Q2 2026 call is “first and foremost, invest in our business… also continue to evaluate profitable growth opportunities… and then share repurchases will remain also a very important part of our capital allocation policy.” (Interpretation: the stated philosophy is unobjectionable; the executed record is the problem — see below.)

Significant acquisitions recently? Not recently — FY2025 acquisition spend was just $6.9m, and there have been no material deals since FY2023’s $515.4m. Historically the company was built by acquisition: Dal-Tile (2002), Unilin (2005), Marazzi (2013), IVC (2015), Godfrey Hirst (2018), plus $569.0m in 2018 and $515.4m in 2023. The verdict on that programme is written in the impairments: $695.8m in 2022 and $877.7m in 2023, spread across all three segments (Global Ceramic $426.9m, Flooring NA $215.8m, Flooring ROW $235.0m). An impairment concentrated in one segment is a bad deal; one taken simultaneously across every segment is a systematic overpayment. $1,983.5m of goodwill and intangibles remains.

Buying back shares? Yes — and the timing has been poor. FY2021: $900.3m at an average price near $180, the largest repurchase in company history, executed at the cycle peak. FY2023: $0, with the stock at its cycle low of $76.02. Then $162.8m (2024), $149.8m (2025), and $60.0m in Q2 2026 for 0.6m shares at roughly $100 — close to the 19 May 2026 low of $94.33. (Interpretation: the multi-year pattern is textbook pro-cyclical and has permanently destroyed roughly a quarter of the 2021 outlay. The Q2 2026 purchase is the first genuine evidence of price discipline in years and deserves credit, but one quarter does not reverse the record.) Weighted-average diluted shares have fallen from 74.8m (2017) to 62.4m (2025), with 60.5m outstanding — a 19% reduction, achieved at an unnecessarily high average cost.

Issuing large amounts of new shares to insiders? No. Stock-based compensation was $30.0m in FY2025 — 0.28% of revenue, 8.1% of net income — against $27.5m (2024) and $20.9m (2023). The 2026 Incentive Plan approved on 21 May 2026 reserves 3,500,000 shares, roughly 5.8% of shares outstanding, over a ten-year term. This is a conventional industrial structure and is not a dilution concern.

Compensation policy of directors/management? The 2026 proxy identifies the most important 2025 measures as Adjusted EPS, TSR relative to the S&P 500, and Adjusted Operating Income, with segment-level EPS and EBITDA metrics for divisional executives. PEO Summary Compensation Table total was $5,184,782 for 2025, with compensation actually paid of $4,806,094. The peer group comprises Builders FirstSource, Carrier, Eastman Chemical, Fortune Brands, Leggett & Platt, Lennox, Masco, Newell, Owens Corning, PPG, RPM, Sherwin-Williams, Stanley Black & Decker, Trane and Whirlpool; the committee targets the 50th percentile.

(Interpretation: the structure has two defects. Paying primarily on Adjusted EPS — $8.96 in FY2025 against GAAP diluted EPS of $5.93, a 34% gap — rewards management on a measure that excludes the impairments that are the direct consequence of the capital-allocation decisions being judged. And the peer group includes Trane, Carrier and Sherwin-Williams, structurally superior businesses whose inclusion flatters relative positioning; the factor model places Mohawk with homebuilding-supply cyclicals — Fortune Brands, Masco, Simpson, UFP, Boise Cascade — not with quality compounders. Relative TSR is in the mix, which is appropriate and mitigating.)

Motivations of management? Alignment is genuinely high on ownership and genuinely weak on revealed behaviour. Jeffrey Lorberbaum beneficially owns 10,078,475 shares (16.5%), including 8,132,685 via Aladdin Partners, L.P.; directors and officers as a group hold 17.9%. That is real skin in the game, and it means the family has borne the −4.2% ten-year annualised return alongside outside shareholders.

Against that: across 99 Form 4 filings since 1 January 2025 there is not a single open-market purchase. Nineteen months containing a 33% drawdown to $94.33 produced zero discretionary buying. The August 2026 transactions were sales into the post-earnings rally — Lorberbaum at $130.26–$132.91, Thiers 13,393 shares at $134.98, Helen 7,000 at $131.52, Repp 225 at $130.59 — all executed under pre-existing Rule 10b5-1 plans, which materially reduces their signal value as timed judgements. (Interpretation: the informative datum is the absence of buying, not the presence of selling. A family already at 16.5% has legitimate diversification needs; but nobody stepped up at $94.) Incoming CEO Paul De Cock held 45,216 shares — modest for a chief executive.

The company’s own pay-versus-performance table is the summary judgement: $100 invested returned $77.55 over five years against a peer group’s $168.32.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No. Mohawk Industries, Inc. is a Delaware corporation and a domestic US filer (CIK 0000851968), listed on the NYSE under MHK, CUSIP 608190104, ISIN US6081901042. It files 10-K/10-Q/8-K and issues Form 1099, not K-1. It carries no MLP or partnership complications and no ADR structure. Secondary listings exist in Germany, Italy, London, Brazil and elsewhere but the primary listing is NYSE.

Dividend policy? There is none. Mohawk has never paid a cash dividend since its 1992 IPO — confirmed by zero dividend events across the full price history and by the absence of any dividend line in the cash flow statements. All shareholder return is via repurchase. (Interpretation: for a mature, cash-generative, ex-growth industrial earning below its cost of capital, the absence of a dividend is a defensible policy only if repurchases are executed with price discipline. The record — $900.3m at the 2021 peak, $0 at the 2023 trough — argues that a dividend would have returned capital more reliably than the buyback did.)

How profitable is the business? Worth restating in one line: FY2025 net margin 3.43%, operating margin 4.54%, ROE 4.66%, ROIC 3.69% — against 2016’s 10.38%, 14.29%, 17.50% and 11.78% respectively. Trailing figures are modestly better (operating margin 5.10%, ROIC 4.69%) but remain roughly half the cost of capital.

Is net income diverging from cash from operations? Yes, favourably and explicably. FY2025 operating cash flow of $1,056.2m was 2.86× net income of $369.9m; the trailing figure is $1,272.8m against $464.1m, roughly 2.7×. The gap is almost entirely depreciation and amortisation of $652.6m exceeding capital expenditure of $440.0m, plus deferred taxes. This is the normal and healthy signature of a mature capital-intensive manufacturer whose asset base was built at higher historical cost than current replacement spending.

(Interpretation: the divergence is benign in direction but should not be read as strength. Operating cash flow exceeding net income by 2.7× in a business earning 4.7% on capital means the assets are liquidating faster than they are earning — cash conversion of this shape is a harvest characteristic, not a compounding one. The H1 2026 doubling of operating cash flow to $426.6m was additionally helped by a $171.0m accounts-payable and accrued-expense release, which is a timing benefit rather than an earnings improvement.)

Risks & Downside

What factors would cause the stock to decline? In descending order of probability-weighted impact: (1) housing turnover remaining at multi-decade lows beyond 2028, invalidating the recovery the price embeds; (2) volume recovering while industry overcapacity caps price, producing incremental operating margins below 20% — the decisive variable; (3) input-cost inflation outrunning pricing, with $77m of underlying inflation in Q2 2026, a further ~$35m sequential step-up guided into Q3 and Q4 “elevated,” against only partial European gas hedging; (4) the Q3 print revealing that Q2 borrowed more heavily from the quarter than management indicated — the guided baseline of $2.38–$2.48 is already a 19–22% sequential decline from the $3.04 ex-refund Q2 base; (5) tariff refunds ceasing and the countertop tariff being denied, removing a current earnings prop; (6) a large debt-funded acquisition or resumed buybacks at elevated prices under the new CEO; (7) further goodwill impairment against the remaining $1,983.5m; (8) a rate back-up, given the −0.25 InterestRate factor loading and +1.44 Market beta.

Risk of a catastrophic loss? Low. Net debt of $1,061.9m at 0.8× EBITDA, cash of $849.6m, a new $1.5bn unsecured revolver signed 12 May 2026, consistently positive free cash flow of $616m–$811m, and $8,544.7m of equity against $13,823.2m of assets. There is no refinancing wall, no covenant stress, no dilution requirement and no single-customer or single-product concentration. Even in the bear scenario — flat revenue and a 4.0% operating margin — the company remains comfortably cash-generative and solvent.

Chance of a total loss? Negligible. Total permanent loss would require the simultaneous destruction of a $4.6bn net productive asset base, a $2.6bn inventory position and a $2.3bn receivables book while $1.9bn of debt sat against $849.6m of cash. No plausible path exists on any reasonable horizon.

(Interpretation: the realistic downside is not insolvency — it is the far duller outcome of a multi-year grind at a sub-cost-of-capital return, with the shares continuing to oscillate within the $76–$164 band they have occupied since 2022. That outcome has already cost owners 6.9% per annum over five years and 4.2% per annum over ten, with a 79% peak-to-trough drawdown. Permanent capital impairment through opportunity cost is the live risk here, and the historical record shows it is not hypothetical.)

Recent News & Events

Has the business environment changed recently? Yes, in three respects, and the net is genuinely ambiguous. Demand: stabilising but not recovering — Q2 2026 revenue grew 6.8% with volume growth across all segments, yet management insists “the market has not yet improved” and that resale activity remains near multi-decade lows. Costs: deteriorating — underlying inflation of $77m in Q2, a similar ~$35m sequential step-up guided into Q3, Q4 “elevated,” driven by a Middle East conflict and European energy, with management warning that “additional price increases may be required.” Policy: improving — tariff refunds worth ~$0.63 per share in Q2 and ~$0.12 guided into Q3, plus a proposed 25% ITC minimum tariff on countertops with a Presidential decision pending.

Significant acquisitions? None of consequence. FY2025 acquisition spend was $6.9m; the last material outlay was $515.4m in FY2023. Management stated on the Q2 call that growth opportunities “have to meet our strategic priorities… and then also they need to achieve our financial return criteria” — a return hurdle that is asserted but not quantified. (Open question.)

Change in accounting policies? Yes, and it is material to the assessment of controls. In Q4 2025 Mohawk identified an intercompany error affecting accounts receivable, undetected for at least three years. Under SAB 108 it revised the 2023 and 2024 consolidated financial statements: accounts receivable reduced $42.1m; 2023 net earnings reduced $9.5m (EPS −$0.15); 2024 reduced $3.0m (EPS −$0.05); 31 December 2022 retained earnings reduced $29.6m. This triggered a clawback of erroneously awarded incentive compensation under the 2023 and 2024 SEAIP, MAIP, LTIP and EEIP plans; relative TSR was unaffected. The proxy does not quantify the amount recovered. Separately, the FY2025 10-K notes ASU 2025-06 on internal-use software as under evaluation, and general corporate expense nearly doubled to $103.4m without explanation.

Recent changes — new markets, facilities, management? Management (the most significant event of the period): on 11 June 2026 Mohawk announced that Paul F. De Cock, 53, becomes CEO and a director effective 30 September 2026, succeeding Jeffrey S. Lorberbaum after 25 years; Lorberbaum remains Chairman. De Cock’s base salary is $1,267,000 with a 125%-of-salary target bonus. He joined via the 2005 Unilin acquisition and ran Unilin North America, Unilin Flooring, then Flooring North America (2018–2025), then COO from February 2025 and interim President of Flooring ROW from February 2026. The stock rose 7.47% on the announcement.

Facilities: a second US domestic countertop manufacturing line has been commissioned ahead of the expected tariff decision, and a new restructuring programme targets ~$60m of annual savings for ~$50m of cash cost through operational simplification, organisational realignment, warehouse consolidation and capacity optimisation, most complete by end-2027.

Financing: a new $1.5bn unsecured revolving credit facility was entered on 12 May 2026 with JPMorgan Chase and J.P. Morgan SE as agents, replacing the October 2019 facility, including a $125m letter-of-credit sublimit, $150m swingline and an accordion feature.

Governance: shareholders approved the 2026 Incentive Plan on 21 May 2026 (3,500,000 shares reserved); a stockholder proposal on a majority vote standard appeared on the 2026 ballot.

(Interpretation: the CEO transition is the item to watch. It is a well-planned internal succession by a deep operator, but it leaves the prior capital-allocation authority in the chairman’s seat with 16.5% of the stock, and the incoming CEO ran the segment that earned a 3.12% operating margin in FY2025. The single most valuable disclosure the new CEO could make is a quantified return hurdle for M&A and repurchase.)

APPENDIX B — Source Appendix

Mohawk Industries, Inc. (NYSE: MHK) — 2026-08-08

All sources accessed 2026-08-08 unless otherwise stated. Primary sources are SEC filings, linked below.

1. SEC Filings — Primary Sources

The trailing 60-month corpus was enumerated (409 filings since 2021-08-01) and 94 primary documents were downloaded and mirrored locally. Form breakdown: 191 Form 4, 80 Form 144, 47 8-K, 15 10-Q, 11 SC 13D/G, 10 Form 3, 10 Form 11-K, 5 DEF 14A, 5 10-K, 5 SD, 3 Form 5, 2 S-3ASR, 1 S-8, 1 PX14A6G, plus 424B and administrative filings.

All filings are publicly available from the SEC EDGAR system under CIK 0000851968.

2. Management Commentary

Management commentary is treated throughout as hypothesis requiring validation, not as evidence. Where management claims (share gains, “permanent structural” savings, limited pre-buy) could not be validated against filings or third-party data, they are labelled Interpretation or flagged as Open Questions.

3. Market, Price and Factor Data

Factor-model outputs are third-party statistical estimates, not primary data. Loadings, returns and drawdowns are reported as Fact; forward inferences drawn from them are labelled Interpretation and are regime-caveated.

4. Third-Party Fundamentals (Cross-Check Only)

Three documented feed defects, corrected rather than propagated:

1. Impairment misclassification. ROIC.ai places MHK’s goodwill and intangible impairments in non-operating income, so is_oper_income of $940.0m (FY2022) and $585.8m (FY2023) are pre-impairment and unusable. The 10-K segment note was used instead; ROIC’s ebit field does reconcile ($244.2m, −$291.9m, $693.5m, $489.8m for 2022–25), verified against the filing: FY2025 segment OI $593.2m − corporate $103.4m = $489.8m → less other expense $3.3m and interest $17.8m = pretax $468.7m ✓.
2. Defective enterprise-value row. For the quarter ended 2026-06-30, get_enterprise_value returned market_cap of $7,340,465,000 with every balance-sheet field null, so enterprise_value equalled a stale quarter-end market cap with no debt bridge. Enterprise value was rebuilt by hand from the filings.
3. Stale valuation-index inputs. The AZI valuation_index snapshot dated 2026-08-07 carried pre-Q2 fundamentals — BVPS 135.8136 reconciles to 2025-12-31 equity, and ttm_eps 6.651 implies ~$406m against an actual LTM net income of $464.1m. Corrected P/E ~17.98× and P/B ~0.96× (the relevant section).

5. Industry and Trade Sources

Industry sizing figures from commercial market-research publishers are used for order-of-magnitude context only and are labelled as such; no conclusion in the memo depends on them.

6. CEO Succession — Corroborating Coverage

The 8-K of 2026-06-11 is the primary source; the above are corroborating only.

7. Analytical Frameworks

8. Known Coverage Gaps

Stated explicitly so the reader can weigh them:

1. ROIC.ai get_company_news returned no results for MHK; the recent-events timeline was rebuilt from filings, the transcript and trade press.
2. No third-party market-share data was obtained to validate management’s share-gain claims; these remain labelled hypothesis.
3. Mohawk does not disclose an organic revenue bridge, so organic versus acquired growth could not be cleanly separated for any year.
4. The driver of the +9.60% session on 2026-06-24 could not be tied to a company filing — no 8-K was filed that day — and is attributed to sector/macro factors as Interpretation.
5. The dollar amount recovered under the clawback is not quantified in the proxy sections reviewed.
6. General corporate expense nearly doubled to $103.4m in FY2025 with no segment-level bridge in the 10-K; the cause is an open question rather than an established fact.
7. Non-earnings management events (conference presentations, strategy days) were not available through the transcript source; only the Q2 2026 earnings call was reviewed in full.